1. Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology. 2006;45:1144–7.
2. Hanly J. et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology. 2015. Of the 1827 patients in the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort that were assessed annually (mean 4.6 years), 38.3% developed LN. Patients with LN were younger, more likely to be men and were black, Asian or Hispanic. LN was associated with ESKD and death.
3. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guidelines for Glomerulonephritis. Kidney Inter Suppl. 2012;2:139–274.
4. Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982–1995. Arch Intern Med. 2000;160:3136–40.
5. Ward MM. Changes in the incidence of end-stage renal disease due to lupus nephritis in the United States, 1996–2004. J Rheumatol. 2009;36(1):63–7.